Protection against reduced proteasomal activity after rotenone exposure in the presence of overexpressed UBA52 also reflects its burgeoning part in sufficient degradation of target proteins such as HSP90 and impedes neurodegeneration during early PD. Here, UBA52 is linked to Parkinson disease.